Sfoglia per Titolo
Doxorubicin metabolism and toxicity in human myocardium : Role of cytoplasmic deglycosidation and carbonyl reduction
2000-01-01 Licata, S; Saponiero, A; Mordente, A; Minotti, G
Doxorubicin metabolism to toxic species in human myocardium: stimulation by paclitaxel and docetaxel but not BMS 184476 or BMS 188797
2000-01-01 Minotti, G; Giancristofaro, G; Menna, P; Salvatorelli, E; Licata, S; Gianni, L
Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: Role of reactive oxygen species and ferritin
2004-01-01 Corna, G; Santambrogio, P; Minotti, G; Cairo, G.
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
2020-01-01 D'Ambrosio, L; Touati, N; Blay, Jy; Grignani, G; Flippot, R; Czarnecka, Am; Piperno-Neumann, S; Martin-Broto, J; Sanfilippo, R; Katz, D; Duffaud, F; Vincenzi, B; Stark, Dp; Mazzeo, F; Tuchscherer, A; Chevreau, C; Sherriff, J; Estival, A; Liti?re, S; Sents, W; Ray-Coquard, I; Tolomeo, F; Le Cesne, A; Rutkowski, P; Stacchiotti, S; Kasper, B; Gelderblom, H; Gronchi, A
Doxorubicin toxicity in human heart: role of C-13 metabolite, c-aconitase and iron
1997-01-01 Minotti, G; C., Mancuso; P., Preziosi; A. M., Calafiore; G., Liberi; G., Cairo
Doxorubicin-Dependent Reduction of Ferrylmyoglobin and Inhibition of Lipid Peroxidation: Implications for Cardiotoxicity of Anticancer Anthracyclines
2002-01-01 Menna, P.; Salvatorelli, E.; Giampietro, R.; Liberi, G.; Teodori, G.; Calafiore, A. M.; Minotti, G
Doxorubicin-Dexrazoxane from day 1 for soft-tissue sarcomas: The road to cardioprotection
2021-01-01 Benjamin, R. S.; Minotti, G.
Doxorubicina citrato in liposoma non pegilato” (DCLNP) nei tumori ginecologici avanzati/recidivant
2005-01-01 M., Calcagno; R., Angioli; I., Palaia; N., Manci; M. A., Zullo; L., Muzii; F., Bellati; Plotti, F; S., Basile; Cl., De Falco; M., Pernice; E., Marullo; P., Benedetti Panici
Doxorubicina citrato in liposoma non pugilato (DCLNP) nei tumori ginecologici avanzati/recidivanti
2005-01-01 M., Calcagno; R., Angioli; I., Palaia; N., Manci; M. A., Zullo; L., Muzii; F., Bellati; Plotti, F; S., Basile; C. L., De Falco; M., Pernice; E., Ma rullo; P., Benedetti Panici
Doxorubicinolone formation and efflux : A salvage pathway against epirubicin accumulation in human heart
2009-01-01 Salvatorelli, E; Menna, P; Lusini, M; Covino, E; Minotti, G
DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19?
2020-01-01 Strollo, R; Pozzilli, P
dRAIN: A distributed Reliable Architecture for IoT Networks
2023-01-01 Petrosino, L.; Pescetelli, G.; Fieramosca, Q.; Valle, S. D.; Merone, M.; Vollero, L.
Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease
2014-01-01 Di Lazzaro, V; Capone, F; Cammarota, G; Di Giuda, D; Ranieri, F
Dramatic improvement of psoriasis with gemcitabine monotherapy
2003-01-01 Landi, D; Santini, D; Vincenzi, B; La Cesa, A; Dianzani, C; Tonini, G
Drawing impairment predicts mortality in severe COPD
2006-01-01 Incalzi, R. A.; Corsonello, A; Pedone, C; Trojano, L; Acanfora, D; Spada, A; Izzo, O; Rengo, F; ANTONELLI INCALZI, RAFFAELE FRANCO
Drawing impairment predicts mortality in severe COPD. A naive approach to COPD mortality prediction (Letter to the Editor)
2007-01-01 Antonelli Incalzi, R.; Pedone, C.; Corsonello, A.; Rengo, F
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma
2010-01-01 Bronte, G; Rizzo, S; La Paglia, L; Adamo, V; Siragusa, S; Ficorella, C; Santini, D; Bazan, V; Colucci, G; Gebbia, N; Russo, A
Droplet-based microfluidic synthesis of nanogels for controlled drug delivery: tailoring nanomaterial properties via pneumatically actuated flow-focusing junction
2022-01-01 Giannitelli, S. M.; Limiti, E.; Mozetic, P.; Pinelli, F.; Han, X.; Abbruzzese, F.; Basoli, F.; Del Rio, D.; Scialla, S.; Rossi, F.; Trombetta, M.; Rosano, L.; Gigli, G.; Zhang, Z. J.; Mauri, E.; Rainer, A.
Drug combination Of AZT And Ddi: Synergism Of Action And Prevention of Appearance of AZT-Resistance
1994-01-01 Antonelli, G; Dianzani, F; Bellarosa, D; Turriziani, O; Riva, E; Gentile, A.
Drug Delivery With Membranes Systems
2018-01-01 Mazzeo, L; Bianchi, M; Cocchi, M; Piemonte, V
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Doxorubicin metabolism and toxicity in human myocardium : Role of cytoplasmic deglycosidation and carbonyl reduction | 1-gen-2000 | Licata, S; Saponiero, A; Mordente, A; Minotti, G | |
| Doxorubicin metabolism to toxic species in human myocardium: stimulation by paclitaxel and docetaxel but not BMS 184476 or BMS 188797 | 1-gen-2000 | Minotti, G; Giancristofaro, G; Menna, P; Salvatorelli, E; Licata, S; Gianni, L | |
| Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: Role of reactive oxygen species and ferritin | 1-gen-2004 | Corna, G; Santambrogio, P; Minotti, G; Cairo, G. | |
| Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group | 1-gen-2020 | D'Ambrosio, L; Touati, N; Blay, Jy; Grignani, G; Flippot, R; Czarnecka, Am; Piperno-Neumann, S; Martin-Broto, J; Sanfilippo, R; Katz, D; Duffaud, F; Vincenzi, B; Stark, Dp; Mazzeo, F; Tuchscherer, A; Chevreau, C; Sherriff, J; Estival, A; Liti?re, S; Sents, W; Ray-Coquard, I; Tolomeo, F; Le Cesne, A; Rutkowski, P; Stacchiotti, S; Kasper, B; Gelderblom, H; Gronchi, A | |
| Doxorubicin toxicity in human heart: role of C-13 metabolite, c-aconitase and iron | 1-gen-1997 | Minotti, G; C., Mancuso; P., Preziosi; A. M., Calafiore; G., Liberi; G., Cairo | |
| Doxorubicin-Dependent Reduction of Ferrylmyoglobin and Inhibition of Lipid Peroxidation: Implications for Cardiotoxicity of Anticancer Anthracyclines | 1-gen-2002 | Menna, P.; Salvatorelli, E.; Giampietro, R.; Liberi, G.; Teodori, G.; Calafiore, A. M.; Minotti, G | |
| Doxorubicin-Dexrazoxane from day 1 for soft-tissue sarcomas: The road to cardioprotection | 1-gen-2021 | Benjamin, R. S.; Minotti, G. | |
| Doxorubicina citrato in liposoma non pegilato” (DCLNP) nei tumori ginecologici avanzati/recidivant | 1-gen-2005 | M., Calcagno; R., Angioli; I., Palaia; N., Manci; M. A., Zullo; L., Muzii; F., Bellati; Plotti, F; S., Basile; Cl., De Falco; M., Pernice; E., Marullo; P., Benedetti Panici | |
| Doxorubicina citrato in liposoma non pugilato (DCLNP) nei tumori ginecologici avanzati/recidivanti | 1-gen-2005 | M., Calcagno; R., Angioli; I., Palaia; N., Manci; M. A., Zullo; L., Muzii; F., Bellati; Plotti, F; S., Basile; C. L., De Falco; M., Pernice; E., Ma rullo; P., Benedetti Panici | |
| Doxorubicinolone formation and efflux : A salvage pathway against epirubicin accumulation in human heart | 1-gen-2009 | Salvatorelli, E; Menna, P; Lusini, M; Covino, E; Minotti, G | |
| DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? | 1-gen-2020 | Strollo, R; Pozzilli, P | |
| dRAIN: A distributed Reliable Architecture for IoT Networks | 1-gen-2023 | Petrosino, L.; Pescetelli, G.; Fieramosca, Q.; Valle, S. D.; Merone, M.; Vollero, L. | |
| Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease | 1-gen-2014 | Di Lazzaro, V; Capone, F; Cammarota, G; Di Giuda, D; Ranieri, F | |
| Dramatic improvement of psoriasis with gemcitabine monotherapy | 1-gen-2003 | Landi, D; Santini, D; Vincenzi, B; La Cesa, A; Dianzani, C; Tonini, G | |
| Drawing impairment predicts mortality in severe COPD | 1-gen-2006 | Incalzi, R. A.; Corsonello, A; Pedone, C; Trojano, L; Acanfora, D; Spada, A; Izzo, O; Rengo, F; ANTONELLI INCALZI, RAFFAELE FRANCO | |
| Drawing impairment predicts mortality in severe COPD. A naive approach to COPD mortality prediction (Letter to the Editor) | 1-gen-2007 | Antonelli Incalzi, R.; Pedone, C.; Corsonello, A.; Rengo, F | |
| Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma | 1-gen-2010 | Bronte, G; Rizzo, S; La Paglia, L; Adamo, V; Siragusa, S; Ficorella, C; Santini, D; Bazan, V; Colucci, G; Gebbia, N; Russo, A | |
| Droplet-based microfluidic synthesis of nanogels for controlled drug delivery: tailoring nanomaterial properties via pneumatically actuated flow-focusing junction | 1-gen-2022 | Giannitelli, S. M.; Limiti, E.; Mozetic, P.; Pinelli, F.; Han, X.; Abbruzzese, F.; Basoli, F.; Del Rio, D.; Scialla, S.; Rossi, F.; Trombetta, M.; Rosano, L.; Gigli, G.; Zhang, Z. J.; Mauri, E.; Rainer, A. | |
| Drug combination Of AZT And Ddi: Synergism Of Action And Prevention of Appearance of AZT-Resistance | 1-gen-1994 | Antonelli, G; Dianzani, F; Bellarosa, D; Turriziani, O; Riva, E; Gentile, A. | |
| Drug Delivery With Membranes Systems | 1-gen-2018 | Mazzeo, L; Bianchi, M; Cocchi, M; Piemonte, V |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile